A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain

Clinical trial NCT05219812 · COMPLETED

Trial details

NCT number: NCT05219812
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Peripheral Neuropathic Pain Diabetes Mellitus

Start date: 2022-02-16
Primary completion: 2022-11-07
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.